£115.00

Advances in the Management of Triple Negative Breast Cancer

Price data last checked 20 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£115 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 71 days · 71 data points (no recent data)

Historical
Generating forecast…
£115.00 £109.25 £111.55 £113.85 £116.15 £118.45 £120.75 09 July 2026 26 July 2026 13 August 2026 30 August 2026 17 September 2026

Price Distribution

Price distribution over 71 days • 1 price levels

Days at Price
71 days 0 18 36 53 71 £115 Days at Price

Price Analysis

Most common price: £115 (71 days, 100.0%)

Price range: £115 - £115

Price levels: 1 different prices over 71 days

Description

Triple-negative breast cancer (TNBC), the focus of this book, is defined by what it is not. It is not positive for hormone receptors (estrogen and progesterone) and it lacks overexpression or gene amplification of HER2. Without these three receptors, the only consistently effective systemic treatment remains chemotherapy with its attendant toxicities. As a result of these narrowed treatment options, and given its relatively aggressive natural history, there is increasing emphasis on both clinical and translational research in this subtype of breast cancer. This book covers the whole spectrum of TNBC management, from risk factors, molecular profiling, and diagnostics to adjuvant chemotherapy and targeted agents. The optimal management of TNBC patients requires the understanding of molecular subgroups of this heterogeneous disease and possible use of combination treatment with conventional and novel targeted therapies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
11 January 2011
Listed Since
06 January 2012

Barcode

No barcode data available

Similar Products You Might Like

Advances in Personalized Therapy for Lung Cancer
99% match

Advances in Personalized Therapy for Lung Cancer

£60.00 08 Sep 2026
Molecular-Based Decision Making for Personalized Cancer Management
99% match

Molecular-Based Decision Making for Personalized Cancer Management

£85.00 23 Sep 2026
Advances in Myocardial Infarction Management
98% match

Advances in Myocardial Infarction Management

£120.00 20 Aug 2026
EGFR Inhibitors in Cancer Treatment
98% match

EGFR Inhibitors in Cancer Treatment

£85.00 03 Oct 2026
Emerging Applications of Colloidal Noble Metals in Cancer Nanomedicine
98% match

Emerging Applications of Colloidal Noble Metals in Cancer Nanomedicine

£60.00 11 Sep 2026
Advances in Asthma Management
98% match

Advances in Asthma Management

£115.00 14 Aug 2026
Clinical Insights: Stereotactic Body Radiation Therapy: Lung Cancer
98% match

Clinical Insights: Stereotactic Body Radiation Therapy: Lung Cancer

£120.00 18 Sep 2026
Advances in Smoking Cessation - Medical Reference Book
98% match

Advances in Smoking Cessation - Medical Reference Book

£155.00 02 Oct 2026
Contemporary Management of Overactive Bladder
98% match

Contemporary Management of Overactive Bladder

£65.00 19 Sep 2026
Targeted Therapies for Non-Small-Cell Lung Cancer
98% match

Targeted Therapies for Non-Small-Cell Lung Cancer

£85.00 03 Oct 2026
Hospital-Acquired Pneumonia
98% match

Hospital-Acquired Pneumonia

£90.00 20 Aug 2026
Critical Care in Spinal Cord Injury
98% match

Critical Care in Spinal Cord Injury

£90.00 19 Aug 2026
Addressing Unmet Medical Needs in COPD Management
98% match

Addressing Unmet Medical Needs in COPD Management

£115.00 14 Aug 2026
Antidepressants & Major Depressive Disorder
98% match

Antidepressants & Major Depressive Disorder

£83.03 23 Sep 2026
Current & Emerging Pharmaceutical Treatments for Cystic Fibrosis Lung Disease
98% match

Current & Emerging Pharmaceutical Treatments for Cystic Fibrosis Lung Disease

£90.00 23 Sep 2026
Gene Therapy: Technologies and Applications
98% match

Gene Therapy: Technologies and Applications

£90.00 20 Aug 2026
Innovations in the Integrated Management of Breast Cancer
98% match

Innovations in the Integrated Management of Breast Cancer

£57.68 10 Sep 2026
Plant-derived Vaccines: Technology & Applications
98% match

Plant-derived Vaccines: Technology & Applications

£115.00 09 Sep 2026
Polycystic Kidney Disease: From Bench to Bedside
98% match

Polycystic Kidney Disease: From Bench to Bedside

£120.00 27 Sep 2026
Value Proposition to Tourism Coopetition: Cases and Tools (Building the Future of Tourism)
98% match

Value Proposition to Tourism Coopetition: Cases and Tools (Building the Future of Tourism)

£63.64 23 Sep 2026
The Emerald Handbook of International Dark Tourism (Building the Future of Tourism)
98% match

The Emerald Handbook of International Dark Tourism (Building the Future of Tourism)

£116.38 24 Sep 2026
Dark Tourism: Theory, Interpretation and Attraction (Building the Future of Tourism)
98% match

Dark Tourism: Theory, Interpretation and Attraction (Building the Future of Tourism)

£67.31 17 Sep 2026
Ewing Sarcoma: Basic Biology, Clinical Challenges and Future Perspectives
98% match

Ewing Sarcoma: Basic Biology, Clinical Challenges and Future Perspectives

£68.49 12 Sep 2026
Breast Cancer: From Bench to Personalized Medicine
98% match

Breast Cancer: From Bench to Personalized Medicine

Springer

£110.00 19 Aug 2026